Identifying high-volume prescribers and engaging with key opinion leaders (KOLs) in a target therapeutic area can be a challenge. In a new webinar, sponsored by PurpleLab, experts explore how PurpleLab’s data solutions can help foster a deeper understanding of physician prescribing behavior.

When evaluating a data partner, make sure you are choosing a trusted data partner that meets all your needs. This handy dandy checklist can help ensure that you’re selecting a trusted data partner.

Learn more about what PurpleLab can do for Clinical Trials Life Sciences Clinical trials are essential for drug development, yet they frequently face delays due to ineffective site selection, leading to protocol violations, compromised data quality, and soaring costs. In fact, 90% of trials fail to meet their timelines, often due to inadequate staffing and…

More than a year has passed since Humira biosimilars were launched in the US, and with these, several other biosimilar drug approvals that either directly compete with Humira or are indicated for other rare immunologic conditions, macular degeneration, and oncology and hematological disease.  Ongoing industry surveillance of biosimilars and the   Source: “Biosimilars are becoming more widely available,…

We provide a real-world data lab to accelerate the discovery and adoption of healthcare innovations. From life science companies, hospitals and health plans to agencies and advertising technology companies, PurpleLab is your trusted real-world-data partner.  Life Sciences Download Let’s Talk! Previous Next

An Antidote to Long-Standing Care and Cost Outcomes Analysis Frustrations Life Sciences Introduction In the ever-evolving landscape of healthcare, life sciences companies face a critical challenge: proving the real-world effectiveness and cost-efficiency of their therapies. ​ While clinical trials establish efficacy, understanding how treatments impact patient outcomes and healthcare costs in the real world remains…

PurpleLab’s® Provider Data is the foundation of our simple to use provider data analytics solutions. This single source of truth provides healthcare organizations with the most comprehensive and up to date provider information Life Sciences Download Let’s Talk! Previous Next

PurpleLab Accelerates Clinical Trial Lifecycle with Real-World-Data This video was created in collaboration with the Applied Clinical Trials. Approximately 80% of clinical trials will face delays at some point in the trial process. Jason Gagner talked with ACT about how PurpleLab uses real-world data to better inform trials and improve their success rates. Learn More About: Utilizing…

This study was run to determine if a racial disparity exists in biomarker testing for NSCLC (non-small cell lung cancer) patients. Jared Safran, PharmD, MS, Russell Robbins, MD, MBA, Maggie Mendes, Douglas Londono, PhD, Grace Kane, MS. Healthcare is evolving into precision medicine or what the FDA refers to as personalized medicine1. This targeted approach…